Back to search

Peptide record

TPDB15300

Antibacterial Toxicity modified_plain modified
7 source-reported length (unverified)
Basic Information
TPDB15300
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
dbAMP DRAMP Peptipedia
modified_plain
Yes
A modified multi-activity (Antibacterial and Toxicity) peptide record curated from dbAMP, DRAMP, and Peptipedia, without an available 3D structural model. Source-reported length: 7 (unverified).
Modified, details unspecified
Sequence
KXWKLXK

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
7 source-reported length (unverified)
Evidence Records 3 records
Evidence 1 Activity

Activity

<1% Hemolysis
Toxicity
25-50 µM
Hemolytic Cytotoxic
<1% Hemolysis | 25-50 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Mono-substitution effects on antimicrobial activity of stapled heptapeptides. | Arch Pharm Res | 2017
Evidence 2 Activity

Activity

<1% Hemolysis
Toxicity
6.3-12.5 µM
Hemolytic Cytotoxic
<1% Hemolysis | 6.3-12.5 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial and Hemolytic Activity of Stapled Heptapeptide Dimers | Bull Korean Chem Soc | 2016
Evidence 3 Activity

Activity

% Hemolysis
Toxicity
1.12 %
Hemolytic
Hemolytic_activity: 0.88%, 0.72%, 0.90%, 1.25%, 0.75%, 0.98%, 1.03% and 1.12% hemolysis against human red blood cells at 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100.0 µM.

Target

erythrocytes

Source & Reference

NA
DRAMP
B KOREAN CHEM SOC